trending Market Intelligence /marketintelligence/en/news-insights/trending/je86g4g6w3x8mac7jd3qcw2 content esgSubNav
In This List

Microbot Medical receives Nasdaq noncompliance notice

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Microbot Medical receives Nasdaq noncompliance notice

Microbot Medical Inc. received a notice from the Nasdaq Stock Market for failing to meet the exchange's $1 minimum bid price listing requirement.

The Israeli medical device company has until Sept. 18 to regain compliance for continued listing on the Nasdaq Capital Market.

To regain compliance, the closing bid price of the company's securities must reach at least $1 per share for a minimum of 10 consecutive business days.